FOX Business’ Gerri Willis reports the federal 340B Drug Pricing Program is facing allegations of fraud and hospital ...

FOX Business' Gerri Willis reports on health care abuse accusations against the federal 340B drug program and the impact of ...

In the quest to reduce drug prices for American consumers, reforming a federal program originally intended to lower costs by ...

The federal 340B program was created to help low-income patients get access to affordable medicine. But government programs ...

A federal drug discount program meant to aid low-income patients now fuels hospital profits and investments. Congress is ...

Readers offer opposing views on whether the healthcare program is living up to its mission.

As pharmaceutical companies push changes to the 340B drug pricing program, safety-net hospitals serving Black and low-income ...

The American Hospital Association expresses concern about Eli Lilly’s January 2026 claims-data policy and invites Lilly to work in good faith with the AHA and our 340B hospital members to find a ...

Reforming the federal 340B Drug Pricing Program is a fast and efficient way to reduce drug costs and protect patients. These days, some 340B hospitals are taking advantage of low-income and uninsured ...

State lawmakers are pushing a measure to expand a controversial federal program that gives hospitals hefty discounts on drugs as the Trump administration seeks to curtail spending within the program.

Mere days before the Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program’s (“Pilot”) scheduled January 1, 2026 effective date, a federal district court granted a ...

The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act. [i] The program, which is administered by the Health ...